315 related articles for article (PubMed ID: 8844998)
21. The nuclear factor NF-IL6 activates human placental lactogen gene expression.
Stephanou A; Handwerger S
Biochem Biophys Res Commun; 1995 Jan; 206(1):215-22. PubMed ID: 7818522
[TBL] [Abstract][Full Text] [Related]
22. U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins.
Rabbi MF; Saifuddin M; Gu DS; Kagnoff MF; Roebuck KA
Virology; 1997 Jun; 233(1):235-45. PubMed ID: 9201233
[TBL] [Abstract][Full Text] [Related]
23. NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells.
Cron RQ; Bartz SR; Clausell A; Bort SJ; Klebanoff SJ; Lewis DB
Clin Immunol; 2000 Mar; 94(3):179-91. PubMed ID: 10692237
[TBL] [Abstract][Full Text] [Related]
24. The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kappaB elements.
Bernier R; Barbeau B; Tremblay MJ; Olivier M
J Immunol; 1998 Mar; 160(6):2881-8. PubMed ID: 9510191
[TBL] [Abstract][Full Text] [Related]
25. Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression.
Mitra D; Sikder SK; Laurence J
Virology; 1995 Dec; 214(2):512-21. PubMed ID: 8553553
[TBL] [Abstract][Full Text] [Related]
26. Involvement of Ets, rel and Sp1-like proteins in lipopolysaccharide-mediated activation of the HIV-1 LTR in macrophages.
Sweet MJ; Stacey KJ; Ross IL; Ostrowski MC; Hume DA
J Inflamm; 1998; 48(2):67-83. PubMed ID: 9656143
[TBL] [Abstract][Full Text] [Related]
27. Reactive oxygen species activate HIV long terminal repeat via post-translational control of NF-kappaB.
Pyo CW; Yang YL; Yoo NK; Choi SY
Biochem Biophys Res Commun; 2008 Nov; 376(1):180-5. PubMed ID: 18765232
[TBL] [Abstract][Full Text] [Related]
28. CREB and COUP-TF mediate transcriptional activation of the human immunodeficiency virus type 1 genome in Jurkat T cells in response to cyclic AMP and dopamine.
Rohr O; Schwartz C; Aunis D; Schaeffer E
J Cell Biochem; 1999 Dec; 75(3):404-13. PubMed ID: 10536364
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional activation of the alpha1(I) procollagen gene and up-regulation of alpha1(I) and alpha1(III) procollagen messenger RNA in dermal fibroblasts from tight skin 2 mice.
Christner PJ; Hitraya EG; Peters J; McGrath R; Jiménez SA
Arthritis Rheum; 1998 Dec; 41(12):2132-42. PubMed ID: 9870870
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
[TBL] [Abstract][Full Text] [Related]
31. Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain.
Trautwein C; Caelles C; van der Geer P; Hunter T; Karin M; Chojkier M
Nature; 1993 Aug; 364(6437):544-7. PubMed ID: 8336793
[TBL] [Abstract][Full Text] [Related]
32. cis-acting regulatory elements in the bovine immunodeficiency virus long terminal repeat.
Fong SE; Pallansch LA; Mikovits JA; Lackman-Smith CS; Ruscetti FW; Gonda MA
Virology; 1995 Jun; 209(2):604-14. PubMed ID: 7778292
[TBL] [Abstract][Full Text] [Related]
33. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
35. Regulation of HIV-1 transcription by NF-IL6 in activated Jurkat T cells.
Buckner AE; Tesmer VM; Bina M
Virus Res; 2002 Oct; 89(1):53-63. PubMed ID: 12367750
[TBL] [Abstract][Full Text] [Related]
36. NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line.
Antoni BA; Rabson AB; Kinter A; Bodkin M; Poli G
Virology; 1994 Aug; 202(2):684-94. PubMed ID: 7913275
[TBL] [Abstract][Full Text] [Related]
37. NF kappa B upstream regulatory sequences of the HIV-1 LTR are involved in the inhibition of HIV-1 promoter activity by the NS proteins of autonomous parvoviruses H-1 and MVMp.
Faisst SR; Faisst S; Grangette C; Schlehofer JR; Rommelaere J
Virology; 1993 Dec; 197(2):770-3. PubMed ID: 8249299
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
39. Down-modulation of HIV-1 LTR activity by an extra-LTR nef gene fragment.
Ludvigsen A; Werner T; Gimbel W; Erfle V; Brack-Werner R
Virology; 1996 Feb; 216(1):245-51. PubMed ID: 8614997
[TBL] [Abstract][Full Text] [Related]
40. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
